MedTrace Logo

Effectiveness and Safety Evaluation of Aqueduct -100 Device

NCT02941211 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 50

Last updated 2016-10-21

No results posted yet for this study

Summary

Evaluation of efficacy and safety of using Aqueduct -100 - Cervical Dilator Device

Conditions

  • Cervix Uteri Dilation

Interventions

DEVICE

Aqueduct -100

Sponsors & Collaborators

  • Aqueduct Medical Ltd

    lead INDUSTRY

Principal Investigators

  • Javier Vico, MD · Hospital General Santa Maria del Puerto, Cádiz

  • Javier Pantoja, MD · Hospital General Santa Maria del Puerto, Cádiz

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Sex
FEMALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2015-01-31
Primary Completion
2015-11-30
Completion
2015-11-30

Countries

  • Spain

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02941211 on ClinicalTrials.gov